FundedIQ
Biotechnology

Constructive Bio: Funding, Investors & Team (Oct 2026)

Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.

www.constructive.bio LinkedIn Saffron Walden, United Kingdom 11-50 employees
Total raised
$72.5M
Rounds
2
Latest
Series A
Sep 2024

Constructive Bio has raised $72.5M across 2 funding rounds on record, the most recent a Series A of $57.5M announced in Sep 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Constructive Bio Company Profile and Key Stats

Total funding raised
$72.5M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$57.5M in Sep 2024
Employees
11-50
reported band
Headquarters
Saffron Walden, United Kingdom

Latest funding round on record: Sep 2024.

Constructive Bio Funding Rounds

Date
Round
Amount
Series A
$57.5M
Seed
$15.0M

Constructive Bio raised $15.0M in a Seed announced in Aug 2022.

2.1 years later, a Series A of $57.5M was announced in Sep 2024.

Constructive Bio Founders and Leadership Team

Name
Role
Contact
Ola (aleksandra) Wlodek
Founder
—
Ola Wlodek
CEO
—

No contact details are on record for this team yet.

Constructive Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M
8,558
$15M

Constructive Bio's latest round of $57.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Constructive Bio in Biotechnology and Saffron Walden

Companies Similar to Constructive Bio

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

Constructive Bio Funding FAQs

What does Constructive Bio do?

Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.

How much funding has Constructive Bio raised?

Constructive Bio has raised $72.5M across 2 rounds on record. The most recent is a Series A of $57.5M announced in Sep 2024.

When did Constructive Bio last raise funding?

Constructive Bio's most recent funding round on record is a Series A of $57.5M, announced in Sep 2024.

Who founded Constructive Bio?

FundedIQ lists Ola (aleksandra) Wlodek (Founder) at Constructive Bio.

Who is the CEO of Constructive Bio?

Ola Wlodek is listed as CEO at Constructive Bio.

Where is Constructive Bio headquartered?

Constructive Bio is based in Saffron Walden, Essex, United Kingdom.

How many employees does Constructive Bio have?

Constructive Bio is in the 11-50 employee band.

How does Constructive Bio's funding compare to other Biotechnology startups?

Constructive Bio's latest round of $57.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Constructive Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Constructive Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.